These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3653461)

  • 1. Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives.
    Schaltegger A; Brunner F; Steiger W; Krebs A
    Dermatologica; 1987; 175(3):136-41. PubMed ID: 3653461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
    Taskinen J; Haarala J; Wartiovaara E; Halmekoski J
    Arch Pharm (Weinheim); 1988 Feb; 321(2):103-6. PubMed ID: 3369924
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure specificity of the antipsoriatic anthrones.
    Krebs A; Schaltegger H; Schaltegger A
    Br J Dermatol; 1981 Aug; 105 Suppl 20():6-11. PubMed ID: 7284267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radicals in skin exposed to dithranol and its derivatives.
    Shroot B; Brown C
    Arzneimittelforschung; 1986 Aug; 36(8):1253-5. PubMed ID: 3022762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
    Müller K; Gürster D; Piwek S; Wiegrebe W
    J Med Chem; 1993 Dec; 36(25):4099-107. PubMed ID: 8258834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
    Mustakallio KK
    Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
    Schaltegger A; Bloch U; Krebs A
    Dermatologica; 1982 Oct; 165(4):363-8. PubMed ID: 7152072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stability of cignolin (dithranol) in ointments containing tar with and without the addition of salicylic acid. Oxidation to danthron and dithranol dimer].
    Müller R; Naumann E; Detmar M; Orfanos CE
    Hautarzt; 1987 Feb; 38(2):107-11. PubMed ID: 3570777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
    Tanzer H; Braun C; Seidel M; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(5-6):155-64. PubMed ID: 2371307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.
    Raab W
    Br J Dermatol; 1976 Aug; 95(2):193-6. PubMed ID: 782506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyl radical damage to DNA sugar and model membranes induced by anthralin (dithranol).
    Müller K; Gürster D
    Biochem Pharmacol; 1993 Nov; 46(10):1695-704. PubMed ID: 8250955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects.
    Müller K
    Gen Pharmacol; 1996 Dec; 27(8):1325-35. PubMed ID: 9304402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of 9-anthron-10-yl radicals formed by antipsoriatic and tumor-promoting 9-anthrones in aqueous buffers.
    Hayden PJ; Chignell CF
    Chem Res Toxicol; 1993; 6(2):231-7. PubMed ID: 8386561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.